Table 2.
Percentage of study women with metabolic alterations according to National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria and pro-oxidant factors by study group.
| Variable | Healthy | Metabolic Syndrome | ||
|---|---|---|---|---|
| Treatment (n = 23) | Placebo (n = 23) | Treatment (n = 23) | Placebo (n = 22) | |
| Hyperglycemia (≥6.05 mmol/L) | 2 (9%, 0%–21%) | 3 (13%, 0%–26%) | 8 (35%, 16%–54%) | 13 (59%, 39%–79%) |
| Hypertriglyceridemia (≥1.65 mmol/L) | 9 (41%, 21%–61%) | 8 (35%, 16%–54%) | 19 (83%, 68%–98%) | 17 (77%, 60%–94%) |
| Hypoalphalipoproteinemia (<1.3 mmol/L) | 4 (17%, 2%–32%) | 3 (13%, 0%–26%) | 13 (57%, 37%–77%) | 8 (38%, 18%–58%) |
| Overweight (≥25 kg/m2) | 15 (68%, 49%–87%) | 13 (57%, 37%–77%) | 20 (87%, 73%–100%) | 20 (91%, 79%–100%) |
| Abdominal obesity (≥88 cm) | 16 (70%, 51%–89%) | 12 (52%, 32%–72%) | 20 (87%, 73%–100%) | 20 (91%, 79%–100%) |
| Hypertension (≥130/85 mmHg) | 7 (30%, 11%–49%) | 9 (39%, 29%–49%) | 13 (57%, 37%–77%) | 18 (82%, 66%–98%) |
| Current smokers (≥2 cigarettes/day) | 2 (9%, 0%–21%) | 1 (4%, 0%–12%) | 3 (13%, 0%–26%) | 4 (18%, 2%–34%) |
| Caffeinate beverages intake (≥2 cup/day) | 5 (22%, 5%–39%) | 4 (17%, 2%–32%) | 8 (38%, 18%–58%) | 6 (27%, 9%–45%) |
| Alcohol intake (>2 glasses/d) | 1 (4%, 0%–12%) | 0 | 2 (9%, 0%–21%) | 1 (4%, 0%–12%) |
| Sedentary lifestyle * | 12 (52%, 32%–72%) | 13 (57%, 37%–77%) | 15 (65%, 50%–80%) | 15 (68%, 49%–87%) |
* Sedentary if had <30 min/d of physical activity. Data show frequency (%, 95% confidence interval).